Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 1

Grady Wulff
February 23, 2023

View both parts of the latest episode of our Meet the Analyst series where our Market Analyst, Grady Wulff, sits down with Dr. Tara Speranza, Healthcare & Biotech Analyst at Bell Potter, to discuss her outlook on the stocks she covers, Orthocell (ASX:OCC), Microba Life Sciences (ASX:MAP), and Monash IVF Group (ASX:MVF).

Take a look at Dr. Tara’s journey, her approach to analysing a company, and the first stock to be discussed, Orthocell (ASX:OCC).

In this video, Dr. Tara discusses:
– (0:59) Becoming a Bell Potter Analyst
– (2:56) Approaches to analysing a company
– (7:18) Orthocell’s global 25-year exclusive agreement
– (7:53) Orthocell’s TGA approval for its Remplir device
– (8:44) Orthocell’s speculative buy rating

Note: This interview was filmed on 7 February 2023.

 

View Part 2 here.

Weekly Wrap 5 August

Sophia Mavridis
August 5, 2022

Morning Bell 4 August

Paulina Peters
August 4, 2022

Morning Bell 3 August

Sophia Mavridis
August 3, 2022

Morning Bell 2 August

Paulina Peters
August 2, 2022

Morning Bell 1 August

Sophia Mavridis
August 1, 2022

Weekly Wrap 29 July

Sophia Mavridis
July 29, 2022

Morning Bell 28 July

Paulina Peters
July 28, 2022

Morning Bell 27 July

Paulina Peters
July 27, 2022

Morning Bell 26 July

Sophia Mavridis
July 26, 2022

Morning Bell 25 July

Sophia Mavridis
July 25, 2022

Weekly Wrap 22 July

Sophia Mavridis
July 22, 2022

Morning Bell 21 July

Paulina Peters
July 21, 2022